STN: BLA 125736
Proper Name: Idecabtagene Vicleucel
Tradename: ABECMA
Manufacturer: Celgene Corporation, a Bristol-Myers Squibb Company
Indications:
- Treatment of adult patients with relapsed or refractory multiple myeloma after two or more prior lines of therapy including an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 monoclonal antibody.
Product Information
Supporting Documents
-
Content current as of:
06/27/2025
